RELX PLC: Stock Analysis and Future Predictions

Aug.26.2022
RELX PLC: Stock Analysis and Future Predictions
RELX stock falls slightly to $28.04, with average trading volume of 891,300 shares. Analysts rate it a "buy".

RELX PLC, trading on the New York Stock Exchange as RELX, closed at $28.04 on Wednesday with no change from the previous day's closing price. The average trading volume over the past five days was 891,300 shares. The stock price decreased by $0.82 in the past week, although it has reached a 17-fold high in the last 12 months. The average trading volume over the past 20 days was 660,680 shares, while the 50-day average trading volume was 1,016,512 shares.

 

Last month, shares of RELX fell by 0.85%. The company's stock reached its lowest point of $27.84 per share on August 23, 22. After rebounding to a 52-week high of $32.71 on January 3, the stock hit a low of $24.81 within the 52-week period. So far this year, the stock has reached a new high but has since dropped by 14.01% or $4.57. Despite this, the price is still down 14.28% from its 52-week high.

 

Valuation Metrics

 

The trailing P/E ratio for RELX PLC (RELX) is 29.06. Its beta is 0.74. Other valuation ratios to consider include a P/S ratio of 5.84, a PB ratio of 12.41, and a price-to-cash-flow ratio of 42.80.

 

The company's payout ratio stands at 52.60%. The latest quarterly dividend paid by the company was $0.4443 per share, which reflects a decline of 7.82% compared to the previous year's $0.4820 per share. The most recent dividend decrease of $0.0377 per share was announced on Friday, July 29, 2022.

 

Financial Health

 

Recently, the quick ratio of RELX PLC for the quarter was 0.50 and the current ratio is also 0.50, indicating that the company may not be able to fulfill its debts. Additionally, the company's long-term debt to equity ratio for the recent quarter was 1.63, and the total debt to equity ratio was 1.89. RELX PLC's EBITDA profit margin was 35.31%, while the operating profit margin for the same period was 27.10%. It has been reported that the company's total profit is $6.44 billion and its revenue is $9.96 billion.

 

Profit Surprises

 

The company had a net income of 1.47 billion USD for this quarter, with a revenue growth of 16.79%.

 

From a technical analysis perspective, let's take a brief look at the price trends of RELX PLC (RELX). As of the close on August 24th, the 9-day RSI was 31.06%, indicating the stock is neutral, and the historical volatility during this timeframe was 10.78%.

 

As of today, the price of RELX is $28.49, a decrease of 2.84% compared to its five-day moving average of $0.82. RELX's current trading price is 2.37% lower than its 20-day simple moving average and 9.84% lower than its 100-day SMA. However, its current price is higher than its 50-day SMA by 7.72% but lower than its 200-day SMA by 11.60%.

 

The random values for K and D are 8.36% and 10.25% respectively, with an average true range (ATR) of 0.36. Over a 14-day period, the random value is 11.30% with an average true range of 0.38, while the RSI (14) is 41.09%. The stock's 9-day MACD oscillator has reached -0.46, while the reading for 14 days is -0.59.

 

Analyst rating.

 

Kepler has upgraded RELX PLC (NYSE code: RELX) to a buy rating in its latest analyst report. Previously, the stock was rated as hold. The consensus rating for RELX PLC (RELX) among analysts is overweight. According to current broker recommendations, zero brokerage firms suggest selling RELX while two suggest holding. There are no analysts who rate the stock as underweight. The stock is rated as overweight by zero analysts while one other analyst rates it as a buy.

 

What is RELX's price target for the next 12 months?

 

Analysts predict a target price range of $32.80 to $32.80, with a median target of $32.80 for RELX PLC (RELX) stock. Based on these predictions, the average target price given by analysts is $32.80.

 

 

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Philip Morris Ukraine Says It Will Invest Another USD 10.00 Million in ZYN Nicotine Pouches This Year
Philip Morris Ukraine Says It Will Invest Another USD 10.00 Million in ZYN Nicotine Pouches This Year
Philip Morris said that after investing USD 5.00 million last year to promote its ZYN nicotine pouch brand in Ukraine, it plans to invest another USD 10.00 million this year to develop the nicotine pouch category and launch a new ZYN line.
Apr.08 by 2FIRSTS.ai
Bangladesh May Remove E-Cigarette Production and Sales Ban in Tobacco Law Amendment
Bangladesh May Remove E-Cigarette Production and Sales Ban in Tobacco Law Amendment
Bangladesh is preparing amendments to its anti-tobacco ordinance that would remove the ban on the production and sale of e-cigarettes and also delete provisions prohibiting the display of tobacco products at points of sale.
Mar.31 by 2FIRSTS.ai
Product | 25-second preheat and 2,250mAh battery: Heaven Gifts’ REJO launches new HNB device on Japanese and UK e-commerce platforms
Product | 25-second preheat and 2,250mAh battery: Heaven Gifts’ REJO launches new HNB device on Japanese and UK e-commerce platforms
REJO, Heaven Gifts’ heated tobacco (HNB) brand, has listed the REJO CUBE on its official website. The device features a magnetic modular design with a detachable battery and an OmniHeat™ 360° heating system, and is now available via e-commerce channels in Japan and the UK, priced at 6,980 yen (about $45) in Japan.
Mar.06 by 2FIRSTS.ai
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
During the “Toxicological Profile” session at FDA’s Feb 10 PMTA roundtable, officials outlined the carcinogenicity tiering system and Excess Lifetime Cancer Risk (ELCR) framework used in ENDS reviews under the APPH standard. Small manufacturers questioned database transparency, exposure assumptions, and the existence of clear compliance benchmarks. FDA reiterated toxicological risk is assessed case by case within a broader population-level determination.
Feb.11
Costa Rica’s Constitutional Court Rejects Challenge, New Vape Rules to Take Effect on August 6
Costa Rica’s Constitutional Court Rejects Challenge, New Vape Rules to Take Effect on August 6
Costa Rica’s Constitutional Court has rejected an injunction seeking to stop a new vape regulation from taking effect, ruling that there was no specific harm to constitutional rights. As a result, Technical Regulation RTCR 519-2025, promoted by the Health Ministry, will enter into force on August 6 as originally planned.
Mar.20 by 2FIRSTS.ai
UK reminds vaping firms to apply for new excise duty registration from April 2026
UK reminds vaping firms to apply for new excise duty registration from April 2026
HMRC has issued a reminder urging vaping manufacturers, importers and warehouse operators to prepare for registration under the UK’s new Vaping Products Duty, with applications opening in April 2026 and the duty taking effect in October.
Feb.10